Keith A. Goldan
Chief Financial Officer; Director · 4 filings · Latest: Jun 1, 2026
ABEONA THERAPEUTICS INC.
Syndax Pharmaceuticals Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SNDX | Keith A. Goldan | Chief Financial Officer | Jun 1, 2026 | Sale | $18.99 | 1,177 | $22.4K | 139,252 | |
SNDX | Goldan Keith A. | — | Jun 1, 2026 | Proposed Sale | $18.99 | 1,177 | $22.4K | — | |
SNDX | Keith A. Goldan | Chief Financial Officer | Feb 9, 2026 | Sale | $21.03 | 3,410 | $71.7K | 140,429 | |
SNDX | Goldan Keith A. | — | Feb 9, 2026 | Proposed Sale | $21.03 | 3,410 | $71.7K | — | |
SNDX | Keith A. Goldan | Chief Financial Officer | Feb 6, 2026 | Sale | $20.62 | 2,082 | $42.9K | 143,839 | |
SNDX | Goldan Keith A. | — | Feb 6, 2026 | Proposed Sale | $20.62 | 2,082 | $42.9K | — | |
SNDX | Goldan Keith A. | — | Jul 16, 2025 | Proposed Sale | $9.29 | 1,296 | $12.0K | — | |
SNDX | Goldan Keith A. | — | Feb 10, 2025 | Proposed Sale | $15.50 | 3,777 | $58.6K | — |